FN1 and irritable bowel syndrome: We demonstrated that the combined relative abundance of Fn and Fp exhibited a good potential for differentiating CD from both HS and IBS, but not for differentiating CD subtype from other intestinal disorders, suggesting that more biomarkers need to be explored.